Skip to content
Review

Radiation-Induced Cell-Death States in Cancer: Toward Biomarker-Guided Radioimmunotherapy.

Sep 2026 · Cancer Letters · Vol 661, pp. 218860 · 0 citations · 173 references
Medicine

TL;DR

This narrative review reframes radiation-induced regulated cell death around four functional outputs: antigen preservation, productive innate sensing, effector-cell access, and suppressive remodeling, and integrates tumor genotype, metabolic state, host lymphocyte reserve, spatial heterogeneity, radiation dose and field design, and checkpoint timing into four provisional states.

Abstract

Radiotherapy can convert local tumor injury into systemic antitumor immunity, but this effect depends less on the nominal mode of cell death than on the tissue state that follows irradiation. This narrative review reframes radiation-induced regulated cell death around four functional outputs: antigen preservation, productive innate sensing, effector-cell access, and suppressive remodeling. We distinguish early endoplasmic-reticulum-stress-associated damage-associated molecular pattern (DAMP) signaling from delayed micronucleus-driven cGAS-STING-type I interferon activation, emphasizing that apoptosis becomes immunogenic only in a permissive context. Ferroptosis offers a tractable but double-edged adjunct because lipid peroxidation can enhance tumor killing while impairing dendritic-cell cross-presentation. Necroptosis and pyroptosis are compartment- and genotype-dependent inflammatory amplifiers, whereas persistent senescence can promote fibrosis, immune suppression, and relapse. We further integrate tumor genotype, metabolic state, host lymphocyte reserve, spatial heterogeneity, radiation dose and field design, and checkpoint timing into four provisional states: primed immunogenic death, lytic but poorly sensed death, smoldering inflammatory suppression, and senescent-persistent residual disease. Serial tissue, blood, and imaging measurements may enable state assignment while preserving temporal and spatial context. These states are proposed for prospective testing rather than as established treatment categories.

View source

Similar papers

Review Open access Oct 2026

Regulated Tumor-cell Death in Chemoimmunotherapy: Mechanisms, Biomarkers, and Clinical Translation

Background/Aim: Immune-checkpoint blockade is most effective when tumor antigens are visible, innate sensing is intact, and effector lymphocytes can enter the tumor microenvironment. This narrative review evaluates regulated tumor-cell death as the mechanistic interface between chemotherapy and checkpoint inhibition. M...

Mariangela Garofalo, L. Kuryk · 0 citations
Review Open access Oct 2026

The Dark Side of Radiotherapy: Experimental Evidence, Biological Mechanisms, and Preventive Strategies for Radiation-Induced Tumor-Promoting Niches

Radiotherapy (RT) is an essential treatment modality for solid tumors and achieves tumor control primarily through radiation-induced cytotoxicity. However, its biological effects extend beyond direct tumor-cell killing. Radiation inevitably affects surrounding normal and tumor-adjacent tissues, inducing inflammatory, s...

Y. J. Choi · 0 citations
Open access Nov 2026

Targeting Mitosis to Reprogram the Tumor Microenvironment: Combination Strategies for Cancer Immunotherapy

Dysregulated mitosis is a therapeutic vulnerability in cancer, but the consequences of mitotic targeting extend beyond tumor-cell death. Chromosome missegregation, micronucleus formation, and chromatin-bridge exposure can activate cytosolic DNA sensing and alter inflammatory signaling, immune recognition, and stromal i...

Fa-Zhi Yu, Shuai-Shuai Ji, Jing Guo et al. · 0 citations
Open access Oct 2026

Astatine-211 injury induces an immunostimulatory melanoma-cell state and promotes systemic antitumor immunity

Targeted alpha therapy is generally evaluated by absorbed dose and direct tumor-cell killing, but whether alpha-particle–injured tumor cells can induce systemic antitumor immunity remains poorly defined. We investigated the immunogenic consequences of astatine-211 (²¹¹At) injury in a prophylactic melanoma vaccination–c...

Koki Mayusumi, Soichiro Magara, Xu-Hao Huang et al. · 0 citations
Open access Oct 2026

Non-invasive electromagnetic fields induce anti-tumor neutrophil reprogramming and enhance checkpoint blockade in breast cancer

Introduction Neutrophil reprogramming toward interferon-activated anti-tumor states represents an emerging mechanism of checkpoint sensitization; however, effective strategies to selectively induce this response in the tumor microenvironment remain elusive. Methods We evaluated Asha Therapy, an investigational non-inva...

Vivek Sharma, C. Khantwal, Kishori Konwar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.